In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses
Poster: In silico immunogenicity risk assessment for fusion proteins and novel antibody modalities